Fed. Circ. Told 10X's IP Loss At Odds With Minerva Ruling
By Andrew Karpan (July 13, 2021, 3:50 PM EDT) -- 10X Genomics is asking the Federal Circuit to review a panel's decision upholding a ruling that the startup infringed Bio-Rad's patents on microfluidic chips used for genetic sequencing, arguing that it can't stand in light of the U.S. Supreme Court's Minerva v. Hologic ruling that narrowed a doctrine blocking inventors from challenging their own patents.
In a rehearing petition lodged Monday, 10X asked the Federal Circuit to give it another go at arguing that the International Trade Commission got it wrong during claims construction when it rejected 10X's invalidity arguments under the doctrine of assignor estoppel, which prevents inventors from challenging...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!